NAC for Nail Biting: What N-Acetylcysteine Can and Can't Do
Science · 5 min read · Published 2026-04-21 · Updated 2026-08-11
By Igor Gazivoda · Founder, Stop Biting
N-acetylcysteine (NAC) has solid evidence for skin picking and hair pulling. Does it work for nail biting? The research, typical doses, and what to expect.
What NAC is and why it matters for BFRBs
N-acetylcysteine (NAC) is an amino acid supplement and antioxidant most commonly known as a mucolytic (used in hospitals to thin mucus and treat acetaminophen overdose). In the BFRB world, it's attracted significant attention because of its effects on glutamate transmission in the brain.
Glutamate is the primary excitatory neurotransmitter and plays a key role in habit and compulsion circuits. NAC modulates glutamate activity in the nucleus accumbens and prefrontal cortex — regions central to habitual and compulsive behavior. The hypothesis is that glutamate dysregulation underlies the repetitive, hard-to-stop quality of BFRBs, and that NAC's normalization of this activity reduces urge intensity.
What the research shows for BFRBs
The strongest evidence for NAC in BFRBs comes from studies on trichotillomania (hair pulling) and excoriation disorder (skin picking). A landmark 2009 double-blind placebo-controlled trial by Grant and colleagues (Archives of General Psychiatry) found that NAC at 1200–2400mg/day produced significantly greater reductions in hair pulling severity than placebo, with 56% of NAC participants rated as "much improved" or "very much improved" compared to 16% for placebo.
For excoriation disorder, a 2016 randomised trial by Grant and colleagues (JAMA Psychiatry) found 47% of NAC participants much or very much improved versus 19% on placebo, at doses of 1200–3000mg/day. A 2022 updated literature review covering 33 published reports — including seven randomised controlled trials — concluded that NAC shows consistent promise across the BFRB category, while cautioning that trials remain small and larger studies are needed.
For nail biting specifically, the evidence is thinner. The main controlled data point is a 2013 double-blind randomised trial in 42 children and adolescents (Ghanizadeh, Derakhshan & Berk): NAC at 800mg/day significantly increased nail length at one month, but the advantage was no longer statistically significant at two months. An earlier small trial by Berk and colleagues (2009) also examined NAC for nail biting. In short: encouraging signals, no definitive adult trial.
Dosing, timing, and what to expect
Clinical trials have used doses ranging from 1200mg to 3000mg per day, typically split into two doses. The most common dose in published studies is 1200–2400mg/day. Effects are not immediate — in the 2009 trichotillomania trial, differences from placebo only emerged after about nine weeks of consistent supplementation.
This delay is important: people often try NAC for two weeks, see no effect, and conclude it doesn't work. The glutamate modulation mechanism takes time to produce behavioral change. If you're going to try NAC, commit to a 10–12 week trial at an appropriate dose before drawing conclusions.
Side effects are generally mild — the most common are gastrointestinal (nausea, diarrhea) and are dose-dependent. Taking NAC with food reduces GI effects. The sulfur smell of NAC can also be unpleasant for some people. At recommended doses, NAC is considered safe for most adults; as with any supplement, consult a healthcare provider if you have existing conditions or take medications.
Who is most likely to benefit from NAC
The BFRB research suggests NAC is most effective for people whose habit has a compulsive quality — where the urge to bite is experienced as intrusive, strong, and hard to resist even when consciously trying not to. If nail biting feels more automatic and low-urgency (happening without noticing, without a strong compulsive pull), the glutamate mechanism may be less relevant.
People with comorbid OCD, anxiety disorders, or who have found behavioral approaches insufficient despite sustained effort are the most common candidates for NAC. It's also worth considering for people who have significant urges even during periods of low stress — the urge-driven profile is a better match for the glutamate mechanism than the purely automatic/stimulus-driven profile.
NAC doesn't replace behavioral intervention — the evidence consistently shows better outcomes when it's combined with HRT rather than used alone. It may reduce the intensity of urges enough that behavioral strategies become more feasible.
The practical case for trying NAC
NAC is inexpensive (approximately $15–$30 for a month's supply at 1200–2400mg/day), widely available without prescription, and has a well-established safety profile at these doses. The risk-benefit calculation is reasonable for people who've had limited success with behavioral approaches alone.
The expectation should be modest: not a cure, but a potential reduction in urge intensity that makes behavioral strategies more manageable. Given the evidence for trichotillomania and skin picking — the closest behavioral relatives to nail biting — the extrapolation is scientifically reasonable, but be clear-eyed that large nail biting-specific trials do not yet exist.
If you try it, keep a simple log of biting frequency during the trial period. NAC's effects are subtle enough that they can be difficult to notice without a baseline comparison. A week of baseline data before starting, then comparison at weeks 4, 8, and 12, gives you something concrete to evaluate rather than relying on subjective impression.
Sources:
- Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66(7):756–763.
- Grant JE, Chamberlain SR, Redden SA, et al. N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2016;73(5):490–496.
- Ghanizadeh A, Derakhshan N, Berk M. N-acetylcysteine versus placebo for treating nail biting: a double-blind randomized placebo-controlled clinical trial. Antiinflamm Antiallergy Agents Med Chem. 2013;12(3):223–228.
- The Potential of N-Acetylcysteine for Treatment of Trichotillomania, Excoriation Disorder, Onychophagia, and Onychotillomania: An Updated Literature Review. 2022.
- TLC Foundation for BFRBs: N-acetylcysteine for Hair Pulling, Skin Picking, and Nail Biting.
This article is general information, not medical advice. Talk to a healthcare provider before starting NAC or any supplement, especially if you have existing conditions, take medication, or are pregnant.